Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients

Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Min Hu,1,2 Fang Zeng,1,2 Zhendi Wang,3 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Clinical Research Center for Prec...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cheng F, Li Q, Wang J, Hu M, Zeng F, Wang Z, Zhang Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	kidney transplantation tacrolimus metabolism pharmacogenetics immunosuppression Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/cee5cb4e64dc438abe9b5bc461b915a1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cee5cb4e64dc438abe9b5bc461b915a1
record_format	dspace
spelling	oai:doaj.org-article:cee5cb4e64dc438abe9b5bc461b915a12021-11-18T19:40:25ZGenetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients1178-7066https://doaj.org/article/cee5cb4e64dc438abe9b5bc461b915a12021-11-01T00:00:00Zhttps://www.dovepress.com/genetic-polymorphisms-affecting-tacrolimus-metabolism-and-the-relation-peer-reviewed-fulltext-article-PGPMhttps://doaj.org/toc/1178-7066Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Min Hu,1,2 Fang Zeng,1,2 Zhendi Wang,3 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, 430022, People’s Republic of China; 3Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of ChinaCorrespondence: Zhendi WangDepartment of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of ChinaEmail wangzhendi@gmail.comYu ZhangDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of ChinaEmail zhangwkp@163.comBackground: Tacrolimus is a key drug in kidney transplantation with a narrow therapeutic index. However, whether tacrolimus exposure variability affects clinical outcomes and adverse reactions remains unknown.Objective: Our study investigated the factors that influence tacrolimus exposure in kidney transplantation recipients and the relationship between tacrolimus concentration and clinical outcomes and adverse reactions.Settings and Methods: We examined the effect of tacrolimus concentration on clinical outcomes and adverse reactions in 201 kidney transplantation recipients, and identified clinical and pharmacogenetic factors that explain tacrolimus exposure.Results: The CYP3A5 genotype was clearly associated with dose-adjusted trough blood tacrolimus concentrations (C0/D), whereas no significant difference was observed in patients with the CYP3A4&ast;1B, CYP3A4&ast;22, ABCB1, ABCC2, POR&ast;28 or PXR alleles. Clinical factors such as red blood cell count, hemoglobin, and albumin were the most useful influence factors affecting tacrolimus C0/D. Besides, Wuzhi capsule increased tacrolimus C0/D in kidney transplantation recipients. Furthermore, higher tacrolimus concentrations were associated with higher diarrhea and post-transplant diabetes mellitus (PTDM) risk but not with acute rejection and chronic allograft kidney dysfunction.Conclusion: Clinical factors, medication, and CYP-enzyme polymorphisms accounted for tacrolimus concentration variability in kidney transplantation recipients. Furthermore, higher tacrolimus concentrations were associated with higher diarrhea and PTDM risk.Keywords: kidney transplantation, tacrolimus, metabolism, pharmacogenetics, immunosuppressionCheng FLi QWang JHu MZeng FWang ZZhang YDove Medical Pressarticlekidney transplantationtacrolimusmetabolismpharmacogeneticsimmunosuppressionTherapeutics. PharmacologyRM1-950ENPharmacogenomics and Personalized Medicine, Vol Volume 14, Pp 1463-1474 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	kidney transplantation tacrolimus metabolism pharmacogenetics immunosuppression Therapeutics. Pharmacology RM1-950
spellingShingle	kidney transplantation tacrolimus metabolism pharmacogenetics immunosuppression Therapeutics. Pharmacology RM1-950 Cheng F Li Q Wang J Hu M Zeng F Wang Z Zhang Y Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
description	Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Min Hu,1,2 Fang Zeng,1,2 Zhendi Wang,3 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, 430022, People’s Republic of China; 3Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of ChinaCorrespondence: Zhendi WangDepartment of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of ChinaEmail wangzhendi@gmail.comYu ZhangDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of ChinaEmail zhangwkp@163.comBackground: Tacrolimus is a key drug in kidney transplantation with a narrow therapeutic index. However, whether tacrolimus exposure variability affects clinical outcomes and adverse reactions remains unknown.Objective: Our study investigated the factors that influence tacrolimus exposure in kidney transplantation recipients and the relationship between tacrolimus concentration and clinical outcomes and adverse reactions.Settings and Methods: We examined the effect of tacrolimus concentration on clinical outcomes and adverse reactions in 201 kidney transplantation recipients, and identified clinical and pharmacogenetic factors that explain tacrolimus exposure.Results: The CYP3A5 genotype was clearly associated with dose-adjusted trough blood tacrolimus concentrations (C0/D), whereas no significant difference was observed in patients with the CYP3A4&ast;1B, CYP3A4&ast;22, ABCB1, ABCC2, POR&ast;28 or PXR alleles. Clinical factors such as red blood cell count, hemoglobin, and albumin were the most useful influence factors affecting tacrolimus C0/D. Besides, Wuzhi capsule increased tacrolimus C0/D in kidney transplantation recipients. Furthermore, higher tacrolimus concentrations were associated with higher diarrhea and post-transplant diabetes mellitus (PTDM) risk but not with acute rejection and chronic allograft kidney dysfunction.Conclusion: Clinical factors, medication, and CYP-enzyme polymorphisms accounted for tacrolimus concentration variability in kidney transplantation recipients. Furthermore, higher tacrolimus concentrations were associated with higher diarrhea and PTDM risk.Keywords: kidney transplantation, tacrolimus, metabolism, pharmacogenetics, immunosuppression
format	article
author	Cheng F Li Q Wang J Hu M Zeng F Wang Z Zhang Y
author_facet	Cheng F Li Q Wang J Hu M Zeng F Wang Z Zhang Y
author_sort	Cheng F
title	Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
title_short	Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
title_full	Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
title_fullStr	Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
title_full_unstemmed	Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
title_sort	genetic polymorphisms affecting tacrolimus metabolism and the relationship to post-transplant outcomes in kidney transplant recipients
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/cee5cb4e64dc438abe9b5bc461b915a1
work_keys_str_mv	AT chengf geneticpolymorphismsaffectingtacrolimusmetabolismandtherelationshiptoposttransplantoutcomesinkidneytransplantrecipients AT liq geneticpolymorphismsaffectingtacrolimusmetabolismandtherelationshiptoposttransplantoutcomesinkidneytransplantrecipients AT wangj geneticpolymorphismsaffectingtacrolimusmetabolismandtherelationshiptoposttransplantoutcomesinkidneytransplantrecipients AT hum geneticpolymorphismsaffectingtacrolimusmetabolismandtherelationshiptoposttransplantoutcomesinkidneytransplantrecipients AT zengf geneticpolymorphismsaffectingtacrolimusmetabolismandtherelationshiptoposttransplantoutcomesinkidneytransplantrecipients AT wangz geneticpolymorphismsaffectingtacrolimusmetabolismandtherelationshiptoposttransplantoutcomesinkidneytransplantrecipients AT zhangy geneticpolymorphismsaffectingtacrolimusmetabolismandtherelationshiptoposttransplantoutcomesinkidneytransplantrecipients
_version_	1718420754210488320

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients

Ejemplares similares